On November 11, Amphenol rose 3.44% in Pre-Market Trading, trading at $82.70/share, with turnover of $1.1303 million.
The move followed continued market digestion of the company’s stronger-than-expected quarterly results and outlook, alongside enhanced shareholder returns and recent analyst target-price increases.
Amphenol previously reported adjusted EPS of $0.80 and revenue of $10.23 billion for the latest quarter, above market expectations of $0.72 and $9.465 billion. It guided next-quarter adjusted EPS to $0.81-$0.83 and revenue to $10.3-$10.5 billion, both ahead of consensus. The company also raised its dividend by 20% and approved a new $4 billion, three-year buyback plan. More recently, UBS and Barclays lifted their price targets to $111, reinforcing the constructive view that has helped extend the stock’s rebound.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments